The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 6.00
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 1.00 (16.667%)
Open: 6.50
High: 6.50
Low: 6.50
Prev. Close: 6.50
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on the Pharm2Farm anti-viral mask project

18 Sep 2020 07:00

RNS Number : 3730Z
Braveheart Investment Group plc
18 September 2020
 

RNS Reach announcement (non-regulatory)

 

18 September 2020

Braveheart Investment Group plc

("Braveheart" or the "Group")

Update on the Pharm2Farm anti-viral mask project

Braveheart Investment Group (AIM: BRH), is pleased to announce that Pharm 2 Farm Limited ("P2F") has placed an order for an automated face mask production line which is expected to be delivered in November 2020 and commissioned by the end of December 2020.

 

The face mask production line, which is manufactured in Europe, has the capacity to produce up to five million standard or anti-viral face masks per month.

 

Conventional surgical type masks typically comprise of three layers, with the inner layer acting as a physical barrier to viruses and bacteria. However, they are only recommended for up to two hours of continual use as this layer can become moist and fail, thereby allowing the virus to penetrate though. P2F has developed a second defensive layer that incorporates its own nanotechnology, which is engineered to kill viruses and bacteria. Combining this new active layer with the physical barrier layer, to produce four layer (ply) masks, is expected to improve user safety over a prolonged use. This new material is currently undergoing testing, specifically, with respect to the time taken to kill viruses, including COVID-19. These tests are, being undertaken at the University of Nottingham and results are expected by the beginning of October. Following a satisfactory outcome of the tests undertaken at the University of Nottingham, it is envisaged that manufacture of the anti-viral face masks will commence in the first quarter of 2021. In the event that these tests do not provide a satisfactory outcome, the production line will be used to produce conventional surgical type masks, which P2F believe could still be produced on a profitable basis.

 

 

 

 

For further information: 

 

 

 

 

Braveheart Investment Group plc

Tel: 01738 587555

Viv Hallam, Executive Director

 

 

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Hornigold

 

 

 

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Heena Karani / Lucy Williams

 

 

About RNS Reach announcements

 

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
 
END
 
 
NRAGPUGWBUPUPWM
Date   Source Headline
2nd Feb 20214:38 pmRNSHolding(s) in Company
2nd Feb 20212:28 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSFurther update re Paraytec Limited
25th Jan 202111:20 amRNSHolding(s) in Company
20th Jan 20214:40 pmRNSSecond Price Monitoring Extn
20th Jan 20214:35 pmRNSPrice Monitoring Extension
18th Jan 20214:01 pmRNSHolding(s) in Company
6th Jan 20214:41 pmRNSSecond Price Monitoring Extn
6th Jan 20214:36 pmRNSPrice Monitoring Extension
6th Jan 20212:06 pmRNSSecond Price Monitoring Extn
6th Jan 20212:01 pmRNSPrice Monitoring Extension
6th Jan 20211:27 pmRNSSpecial Dividend payment and Cash position
6th Jan 202111:05 amRNSSecond Price Monitoring Extn
6th Jan 202111:00 amRNSPrice Monitoring Extension
4th Jan 20212:06 pmRNSSecond Price Monitoring Extn
4th Jan 20212:01 pmRNSPrice Monitoring Extension
31st Dec 20201:00 pmRNSTotal Voting Rights
24th Dec 202010:43 amRNSRecent share price
23rd Dec 20204:41 pmRNSSecond Price Monitoring Extn
23rd Dec 20204:36 pmRNSPrice Monitoring Extension
23rd Dec 20202:06 pmRNSSecond Price Monitoring Extn
23rd Dec 20202:01 pmRNSPrice Monitoring Extension
23rd Dec 202011:05 amRNSSecond Price Monitoring Extn
23rd Dec 202011:00 amRNSPrice Monitoring Extension
18th Dec 20202:05 pmRNSSecond Price Monitoring Extn
18th Dec 20202:00 pmRNSPrice Monitoring Extension
18th Dec 202011:25 amRNSFurther update re Paraytec Limited
17th Dec 20207:00 amRNSDirector/PDMR Shareholding
10th Dec 20205:28 pmRNSDirector/PDMR Shareholding
10th Dec 20202:05 pmRNSSecond Price Monitoring Extn
10th Dec 20202:00 pmRNSPrice Monitoring Extension
8th Dec 202010:00 amRNSFurther re. Block Listing
4th Dec 20206:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20209:05 amRNSSecond Price Monitoring Extn
3rd Dec 20209:00 amRNSPrice Monitoring Extension
3rd Dec 20207:10 amRNSExercise of Options & Block Admission Application
3rd Dec 20207:05 amRNSSpecial Dividend
3rd Dec 20207:00 amRNSHalf-year Report
1st Dec 20207:00 amRNSTotal Voting Rights
24th Nov 202011:41 amRNSExercise of Warrants and Issue of Equity
23rd Nov 20204:37 pmRNSShare transactions in Remote Monitored Systems plc
18th Nov 20206:07 pmRNSHolding(s) in Company
18th Nov 20206:07 pmRNSShare transactions in Remote Monitored Systems plc
17th Nov 20205:27 pmRNSHolding(s) in Company
17th Nov 20205:17 pmRNSShare transactions in Remote Monitored Systems plc
12th Nov 202012:18 pmRNSExercise of Warrants and Issue of Equity
10th Nov 20207:00 amRNSFurther update re Paraytec Limited
9th Nov 20207:01 amRNSHolding(s) in Company
9th Nov 20207:00 amRNSShare transactions in Remote Monitored Systems plc
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.